Increasing cognitive assessment rates for older adults in the community
Davos Alzheimer's Collaborative Healthcare System Preparedness to Increase Cognitive Assessment Rates for Older Adults
NA · Ludwig-Maximilians - University of Munich · NCT06191952
This study is testing different ways to improve memory and thinking tests for older adults in community centers to help spot early signs of dementia.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 500 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Ludwig-Maximilians - University of Munich (other) |
| Locations | 1 site (München, Bayern) |
| Trial ID | NCT06191952 on ClinicalTrials.gov |
What this trial studies
This study explores a pragmatic strategy to enhance cognitive screening rates among older adults in community settings. It involves a cluster-randomized approach comparing various combinations of subjective cognitive decline questionnaires, digital cognitive tests, and blood biomarkers for Alzheimer's Disease. Participants will be older adults attending social and cultural centers in the greater Munich area, and qualitative interviews will be conducted with general practitioners and patients to assess the acceptability of the new screening strategy. The initiative aims to provide insights into effective early recognition and prevention of dementia.
Who should consider this trial
Good fit: Ideal candidates for this study are older adults aged 65 years or older.
Not a fit: Patients younger than 65 years will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved early detection and management of cognitive decline in older adults.
How similar studies have performed: Other studies have shown success in increasing cognitive screening rates using similar community-based approaches.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age 65 years or older Exclusion Criteria: * younger than 65 years
Where this trial is running
München, Bayern
- Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums — München, Bayern, Germany (RECRUITING)
Study contacts
- Principal investigator: Robert Perneczky, Prof. Dr. — Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums
- Study coordinator: Dr. Kurz
- Email: Psy.Alzheimerzentrum@med.uni-muenchen.de
- Phone: +4989440055863
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Subjective Cognitive Decline, Alzheimer Dementia, Mild Cognitive Impairment, Community Setting, Digital Cognitive Tests, Blood Biomarker